Literature DB >> 17942693

Isolates of Zaire ebolavirus from wild apes reveal genetic lineage and recombinants.

Tatiana J Wittmann1, Roman Biek, Alexandre Hassanin, Pierre Rouquet, Patricia Reed, Philippe Yaba, Xavier Pourrut, Leslie A Real, Jean-Paul Gonzalez, Eric M Leroy.   

Abstract

Over the last 30 years, Zaire ebolavirus (ZEBOV), a virus highly pathogenic for humans and wild apes, has emerged repeatedly in Central Africa. Thus far, only a few virus isolates have been characterized genetically, all belonging to a single genetic lineage and originating exclusively from infected human patients. Here, we describe the first ZEBOV sequences isolated from great ape carcasses in the Gabon/Congo region that belong to a previously unrecognized genetic lineage. According to our estimates, this lineage, which we also encountered in the two most recent human outbreaks in the Republic of the Congo in 2003 and 2005, diverged from the previously known viruses around the time of the first documented human outbreak in 1976. These results suggest that virus spillover from the reservoir has occurred more than once, as predicted by the multiple emergence hypothesis. However, the young age of both ZEBOV lineages and the spatial and temporal sequence of outbreaks remain at odds with the idea that the virus simply emerged from a long-established and widespread reservoir population. Based on data from two ZEBOV genes, we also demonstrate, within the family Filoviridae, recombination between the two lineages. According to our estimates, this event took place between 1996 and 2001 and gave rise to a group of recombinant viruses that were responsible for a series of outbreaks in 2001-2003. The potential for recombination adds an additional level of complexity to unraveling and potentially controlling the emergence of ZEBOV in humans and wildlife species.

Entities:  

Mesh:

Year:  2007        PMID: 17942693      PMCID: PMC2040453          DOI: 10.1073/pnas.0704076104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  MrBayes 3: Bayesian phylogenetic inference under mixed models.

Authors:  Fredrik Ronquist; John P Huelsenbeck
Journal:  Bioinformatics       Date:  2003-08-12       Impact factor: 6.937

2.  Phylogenetic analysis reveals a low rate of homologous recombination in negative-sense RNA viruses.

Authors:  Elizabeth R Chare; Ernest A Gould; Edward C Holmes
Journal:  J Gen Virol       Date:  2003-10       Impact factor: 3.891

3.  Sequence analysis of the GP, NP, VP40 and VP24 genes of Ebola virus isolated from deceased, surviving and asymptomatically infected individuals during the 1996 outbreak in Gabon: comparative studies and phylogenetic characterization.

Authors:  Eric M Leroy; Sylvain Baize; Elie Mavoungou; Cristian Apetrei
Journal:  J Gen Virol       Date:  2002-01       Impact factor: 3.891

4.  MODELTEST: testing the model of DNA substitution.

Authors:  D Posada; K A Crandall
Journal:  Bioinformatics       Date:  1998       Impact factor: 6.937

5.  Catastrophic ape decline in western equatorial Africa.

Authors:  Peter D Walsh; Kate A Abernethy; Magdalena Bermejo; Rene Beyers; Pauwel De Wachter; Marc Ella Akou; Bas Huijbregts; Daniel Idiata Mambounga; Andre Kamdem Toham; Annelisa M Kilbourn; Sally A Lahm; Stefanie Latour; Fiona Maisels; Christian Mbina; Yves Mihindou; Sosthène Ndong Obiang; Ernestine Ntsame Effa; Malcolm P Starkey; Paul Telfer; Marc Thibault; Caroline E G Tutin; Lee J T White; David S Wilkie
Journal:  Nature       Date:  2003-04-06       Impact factor: 49.962

6.  PAML: a program package for phylogenetic analysis by maximum likelihood.

Authors:  Z Yang
Journal:  Comput Appl Biosci       Date:  1997-10

7.  Ebola outbreak killed 5000 gorillas.

Authors:  Magdalena Bermejo; José Domingo Rodríguez-Teijeiro; Germán Illera; Alex Barroso; Carles Vilà; Peter D Walsh
Journal:  Science       Date:  2006-12-08       Impact factor: 47.728

8.  Multiple Ebola virus transmission events and rapid decline of central African wildlife.

Authors:  Eric M Leroy; Pierre Rouquet; Pierre Formenty; Sandrine Souquière; Annelisa Kilbourne; Jean-Marc Froment; Magdalena Bermejo; Sheilag Smit; William Karesh; Robert Swanepoel; Sherif R Zaki; Pierre E Rollin
Journal:  Science       Date:  2004-01-16       Impact factor: 47.728

Review 9.  Ecologic and geographic distribution of filovirus disease.

Authors:  A Townsend Peterson; John T Bauer; James N Mills
Journal:  Emerg Infect Dis       Date:  2004-01       Impact factor: 6.883

10.  Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.

Authors:  Nancy J Sullivan; Thomas W Geisbert; Joan B Geisbert; Ling Xu; Zhi-Yong Yang; Mario Roederer; Richard A Koup; Peter B Jahrling; Gary J Nabel
Journal:  Nature       Date:  2003-08-07       Impact factor: 49.962

View more
  58 in total

1.  Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine.

Authors:  J Brian Kimble; Delphine C Malherbe; Michelle Meyer; Bronwyn M Gunn; Marcus M Karim; Philipp A Ilinykh; Mathieu Iampietro; Khaled S Mohamed; Surendra Negi; Pavlo Gilchuk; Kai Huang; Yuri I Wolf; Werner Braun; James E Crowe; Galit Alter; Alexander Bukreyev
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  Novel adenoviruses in wild primates: a high level of genetic diversity and evidence of zoonotic transmissions.

Authors:  Diana Wevers; Sonja Metzger; Fred Babweteera; Marc Bieberbach; Christophe Boesch; Kenneth Cameron; Emmanuel Couacy-Hymann; Mike Cranfield; Maryke Gray; Laurie A Harris; Josephine Head; Kathryn Jeffery; Sascha Knauf; Felix Lankester; Siv Aina J Leendertz; Elizabeth Lonsdorf; Lawrence Mugisha; Andreas Nitsche; Patricia Reed; Martha Robbins; Dominic A Travis; Zinta Zommers; Fabian H Leendertz; Bernhard Ehlers
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

3.  Homologous recombination is very rare or absent in human influenza A virus.

Authors:  Maciej F Boni; Yang Zhou; Jeffery K Taubenberger; Edward C Holmes
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

4.  Caution about Newcastle disease virus-based live attenuated vaccine.

Authors:  Guan-Zhu Han; Xi-Ping Liu; Si-Shen Li
Journal:  J Virol       Date:  2008-07       Impact factor: 5.103

5.  What are the risks--hypothetical and observed--of recombination involving live vaccines and vaccine vectors based on nonsegmented negative-strain RNA viruses?

Authors:  Peter L Collins; Alexander Bukreyev; Brian R Murphy
Journal:  J Virol       Date:  2008-10       Impact factor: 5.103

6.  The effect of vaccination on the evolution and population dynamics of avian paramyxovirus-1.

Authors:  Yee Ling Chong; Abinash Padhi; Peter J Hudson; Mary Poss
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

7.  High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon.

Authors:  Pierre Becquart; Nadia Wauquier; Tanel Mahlakõiv; Dieudonné Nkoghe; Cindy Padilla; Marc Souris; Benjamin Ollomo; Jean-Paul Gonzalez; Xavier De Lamballerie; Mirdad Kazanji; Eric M Leroy
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

8.  Guidelines for identifying homologous recombination events in influenza A virus.

Authors:  Maciej F Boni; Menno D de Jong; H Rogier van Doorn; Edward C Holmes
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

9.  No observed effect of homologous recombination on influenza C virus evolution.

Authors:  Guan-Zhu Han; Maciej F Boni; Si-Shen Li
Journal:  Virol J       Date:  2010-09-14       Impact factor: 4.099

10.  Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus.

Authors:  Xavier Pourrut; Marc Souris; Jonathan S Towner; Pierre E Rollin; Stuart T Nichol; Jean-Paul Gonzalez; Eric Leroy
Journal:  BMC Infect Dis       Date:  2009-09-28       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.